Colombia’s President Ivan Duque last week signed a decree lifting the export ban on dried cannabis flower from the South American country, Reuters reports.

Field Trip Health to commence trading on the NASDAQ on July 27th under the symbol “FTRP”.

Cybin Inc is seeking to raise capital with an overnight offering of common shares. Pricing and size of the offering to be determined.

The Mental Health Crisis has been ignored for decades. Covid-19 has made this mental health catastrophe much worse — and people are now starting to notice.

Cybin’s new financing is priced at CAD$3.40. The Company intends to issue 8.8 million new units for total proceeds of CAD$30 million.

MindMed is preparing to commence a Phase I clinical trial on the safety/tolerance of intravenous DMT.

Atai Life Sciences announces the launch of a new intranasal drug delivery system, InnarisBio, based on sol-gel technology.

We explain why addiction therapy likely offers the greatest long-term commercialization potential within the psychedelic drug industry.

Novamind seeks to increase access for U.S. investors through its OTC application.

Cybin announces a conditional listing on the NYSE American exchange.